semaglutide and cardiovascular outcomes in obesity without diabetes patients with and prevalent heart failure: a prespecified analysis of the SELECT trial Semaglutide as a GLP-1 Agonist:

Always consult a healthcare provider if unsure

Pernicious anemia develops when your body cannot make enough healthy red blood cells because it doesnt have enough vitamin B12

Aly-Aly concluded that treating obesity and metabolic syndrome with GLP-1s is likely to have broad benefits that extend beyond just reducing BMI or reducing weight, while the drugs hold promise for addressing other diseases.

7 Additional interactions of the UPS in ferroptosis Recent research has shown that ubiquitin-specific peptidase 11 (USP11) regulates autophagy-dependent ferroptosis in response to spinal cord ischemia-reperfusion injury by deubiquitinating Beclin 1